Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)
DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)
DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays
巴克莱维持DJ Blueprint Medicines的同等权重
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
February 18, 2021 09:57 ET (14:57 GMT)
2021年2月18日09:57美国东部时间(格林尼治标准时间14:57)
DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
巴克莱将DJ Blueprint药品目标价从每股90.00美元上调至95.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
February 18, 2021 09:57 ET (14:57 GMT)
2021年2月18日09:57美国东部时间(格林尼治标准时间14:57)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧